Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice.
FGF21
GDF15
Insulin resistance
Obesity
Journal
Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
18
06
2022
revised:
26
08
2022
accepted:
28
08
2022
pubmed:
6
9
2022
medline:
12
10
2022
entrez:
5
9
2022
Statut:
ppublish
Résumé
Obesity in humans and mice is associated with elevated levels of two hormones responsive to cellular stress, namely GDF15 and FGF21. Over-expression of each of these is associated with weight loss and beneficial metabolic changes but where they are secreted from and what they are required for physiologically in the context of overfeeding remains unclear. Here we used tissue selective knockout mouse models and human transcriptomics to determine the source of circulating GDF15 in obesity. We then generated and characterized the metabolic phenotypes of GDF15/FGF21 double knockout mice. Circulating GDF15 and FGF21 are both largely derived from the liver, rather than adipose tissue or skeletal muscle, in obese states. Combined whole body deletion of FGF21 and GDF15 does not result in any additional weight gain in response to high fat feeding but it does result in significantly greater hepatic steatosis and insulin resistance than that seen in GDF15 single knockout mice. Collectively the data suggest that overfeeding activates a stress response in the liver which is the major source of systemic rises in GDF15 and FGF21. These hormones then activate pathways which reduce this metabolic stress.
Identifiants
pubmed: 36064109
pii: S2212-8778(22)00158-2
doi: 10.1016/j.molmet.2022.101589
pmc: PMC9486046
pii:
doi:
Substances chimiques
GDF15 protein, human
0
Gdf15 protein, mouse
0
Growth Differentiation Factor 15
0
Hormones
0
fibroblast growth factor 21
0
Fibroblast Growth Factors
62031-54-3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101589Subventions
Organisme : Medical Research Council
ID : MR/R023131/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/7/33636
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/2
Pays : United Kingdom
Organisme : Department of Health
ID : CL-2019-14-504
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208363/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M004422/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 219417
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 214274/Z/18/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier GmbH.. All rights reserved.